# DESCRIPTION

## FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT

- acknowledge government support

## TECHNICAL FIELD

- introduce technical field of molecular diagnostics

## BACKGROUND

- motivate need for rapid pathogen diagnosis
- describe limitations of current diagnostic methods
- highlight importance of rapid diagnosis for effective treatment

## SUMMARY

- introduce invention for diagnosing disease and identifying pathogens
- describe method for determining drug sensitivity
- outline steps for determining drug sensitivity
- describe use of nucleic acid probes
- explain binding of probes to target mRNA
- describe comparison of mRNA levels to determine drug sensitivity
- mention use of multiple test compounds
- describe application to unknown pathogens
- outline method for identifying infectious disease pathogens
- describe use of probes to detect target mRNA
- explain determination of pathogen identity
- mention use of microfluidic devices
- describe application to public health surveillance

## DETAILED DESCRIPTION

- describe rapid, highly sensitive, phenotypic-based methods for identifying a pathogen and its drug resistance pattern
- motivate need for rapid diagnosis of TB due to slow growth of TB
- describe alternative approach to determining drug resistance based on defining genotype of infecting pathogen
- introduce digital gene expression with molecular barcodes for detecting early transcriptional responses to drug exposure
- describe use of hybridization of bar-coded probes to mRNA molecules in crude lysates for detection of mRNA
- highlight advantages of the technology, including rapid, simple sample processing and high sensitivity

### RNA Extraction

- describe enzymatic methods for removing cell walls
- describe chemical methods for disrupting lipid barrier surrounding cells
- describe physical disruption of cells using sonication, French press, electroporation, or microfluidic devices
- highlight importance of selecting appropriate method for cell lysis
- mention use of other disruption methods by skilled practitioners

### Rapid, Phenotypic Diagnosis of Pathogen Identity and Pathogen Drug Resistance Using Expression Signatures

- describe use of unique genes to identify pathogens
- describe principle of accelerated resistance testing based on detecting differences in transcriptional response to drug exposure
- outline steps for performing test, including partitioning sample, exposing to drugs, and analyzing expression profiles

### Methods of Treatment

- describe use of methods to identify pathogen and determine drug sensitivity for treatment of disorders
- highlight importance of administering therapeutically effective amount of therapeutic compound

### Methods of Diagnosis

- describe methods for identifying pathogen and determining drug sensitivity using mRNA evaluation

### Kits

- describe kits comprising probes that hybridize with regions of genes associated with pathogens
- highlight inclusion of additional elements, such as instructions, labels, and reagents
- mention kits for self-testing and mailer for returning sample for analysis

## EXAMPLES

### Example 1

- identify pathogens
- design probes for pathogen identification
- demonstrate pathogen identification

### Example 2

- demonstrate sensitivity of methods
- detect pathogens in clinical samples

### Example 3

- identify fluoroquinolone and aminoglycoside resistance in E. coli
- design probes for drug resistance
- demonstrate drug resistance identification
- identify methicillin resistance in S. aureus
- identify vancomycin resistance in Enterococcus
- detect drug resistance in TB
- design probes for TB drug resistance
- demonstrate TB drug resistance identification

### Example 4

- define signature for TB identification
- bioinformatic gene analysis for conserved TB genes
- expression profile analysis of mRNA levels of candidate genes
- probe selection of expression signature identifying TB
- define signature to distinguish sensitive and resistant TB
- expression profiling in response to antibiotic exposure
- develop analysis algorithm to identify drug resistance
- optimize conditions for producing robust profiles
- identify genes for each drug with high induction in sensitive strains
- compare expression levels between sensitive and resistant strains
- develop algorithm to analyze expression ratios
- normalize expression levels to housekeeping genes
- compare to standard sensitive and resistant control strains
- analyze impact of pre-antibiotic exposure on TB bacilli signatures
- pre-expose TB bacilli to common antibiotics
- determine efficacy of signatures to identify resistance patterns
- optimize sample processing for digital gene expression
- address issues with sputum viscosity and bacterial lysis
- test various methods of sputum processing and bacterial lysis
- evaluate alternative methods for bacterial lysis

### Example 5

- describe bacterial and fungal culture
- derive resistant laboratory bacterial strains
- infect cells with viruses and parasites
- expose cultures to antibiotics
- process samples for NanoString analysis
- select organism identification probes
- design probe sets for Gram-negative organisms
- design probe sets for mycobacterial organisms
- design probes for genes differentially regulated by antibiotics
- measure expression signatures in response to antibiotics
- calculate mean-squared distance for drug-sensitivity
- calculate distance metric for organism identification
- apply metrics to laboratory and clinical isolates
- analyze data for drug-sensitivity and organism identification
- discuss results for drug-sensitivity testing
- discuss results for organism identification
- conclude on the potential of RNA expression signatures for pathogen identification and antimicrobial susceptibility testing

## Other Embodiments

- describe scope of invention

